ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

Controlled local delivery of CTLA-4 blocking antibody induces CD8+ T-cell-dependent tumor eradication and decreases risk of toxic side effects.

Marieke F Fransen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.